无创呼吸机联合重组人脑利钠肽治疗急性心力衰竭合并严重呼吸困难患者的临床疗效

doi:10.3969/j.issn.1671-7171.2024.10.013

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1212 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨无创呼吸机联合重组人脑利钠肽治疗急性心力衰竭合并重度呼吸障碍患者的临床效果。【方法】选取2018年1月至2023年1月在安庆市立医院重症医学科接受治疗的急性心力衰竭合并严重呼吸困难的84例患者,按照随机数字表法分为观察组(无创呼吸机联合重组人脑利钠肽治疗)和对照组(采用无创呼吸机治疗),每组42例。比较两组患者心功能[左心室射血分数(LVEF)、左心室收缩末内径(LVESD)、左心室舒张末内径(LVEDD)、中心静脉压(CVP)、速度时间积分(VTI)]、肺部B线积分、血气指标[动脉血二氧化碳分压(PaCO₂)、血氧饱和度(SaO₂)、动脉血氧分压(PaO₂)、动脉血氧饱和度(SpO₂)]、心肌损伤标志物[心肌肌钙蛋白T (cTnT)、cTnI和脑钠肽(BNP)]、呼吸困难指数[慢性阻塞性肺疾病评分(mMRC)];采用Pearson分析患者心功能指标和mMRC的相关性。【结果】治疗后,观察组LVESD、LVEDD、肺部B线积分、CVP、PaCO₂、心肌损伤标志物水平和mMRC均低于对照组,LVEF、 VTI、SaO₂、PaO₂、SpO₂高于对照组(P<0.05)。Pearson分析结果显示:mMRC与LVESD、LVEDD、CVP呈正相关,与LVEF呈负相关(P<0.05)。【结论】AHF合并严重呼吸困难患者进行无创呼吸机与重组人脑利钠肽联合治疗,可降低患者心脏和呼吸肌的负担,并优化心肺功能与气体交换。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王立娟
	李川

关键词 ：心力衰竭/并发症, 急性病, 呼吸困难, 呼吸,人工, 利钠肽,脑/药理学

Abstract：【Objective】To investigate the clinical effect of noninvasive ventilator combined with recombinant human brain natriuretic peptide in the treatment of acute heart failure complicated with severe respiratory disorders. 【Methods】A total of 84 patients with acute heart failure combined with severe dyspnea who were treated in the Intensive Care Department of the Anqing Municipal Hospital from January 2018 to January 2023 were selected and divided into the observation group (noninvasive ventilator combined with recombinant human brain natriuretic peptide treatment) and the control group (noninvasive ventilator treatment) according to random number table method, with 42 cases in each group. The two groups were compared in terms of cardiac function [left ventricular ejection fraction (LVEF), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), central venous pressure (CVP), velocity time integral (VTI)], lung B-line integral and blood gas index (PaCO₂), blood oxygen saturation (SaO₂), partial arterial oxygen pressure (PaO₂), arterial oxygen saturation (SpO₂), myocardial injury markers [cardiac troponin T(cTnT), cTnI and brain natriuretic peptide (BNP)], dyspnea index [Chronic obstructive Pulmonary disease score (mMRC)]; The correlation between cardiac function indexes and mMRC was analyzed by Pearson. 【Results】After treatment, LVESD, LVEDD, lung B-line score, CVP, PaCO₂, myocardial injury markers and mMRC in observation group were lower than those in control group, while LVEF, VTI, SaO₂, PaO₂ and SpO₂ were higher than those in control group(P<0.05). The results of Pearson analysis showed that mMRC was positively correlated with LVESD, LVEDD and CVP, and negatively correlated with LVEF (P<0.05). 【Conclusion】The combination of noninvasive ventilator and recombinant human brain natriuretic peptide therapy in patients with severe dyspnea with AHF can reduce the burden on the heart and respiratory muscles, and optimize the cardiopulmonary function and gas exchange.

Key words： Heart Failure/CO Acute Disease Dyspnea Respiration, Artificial Natriuretic Peptide, Brain/PD

收稿日期: 2024-06-18

中图分类号:

R541.61

通讯作者: *E-mail:lichuan1269@163.com

引用本文:

王立娟, 李川. 无创呼吸机联合重组人脑利钠肽治疗急性心力衰竭合并严重呼吸困难患者的临床疗效[J]. 医学临床研究, 2024, 41(10): 1501-1504.
WANG Lijuan, LI Chuan. Clinical Efficacy of Noninvasive Ventilator Combined with Recombinant Human Brain Natriuretic Peptide in the Treatment of Acute Heart Failure Patients with Severe Dyspnea. JOURNAL OF CLINICAL RESEARCH, 2024, 41(10): 1501-1504.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.10.013 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I10/1501

[1] 中华医学会急诊医学分会心脑血管病学组.中国急诊急性心力衰竭单元建设与管理专家共识[J].中华急诊医学杂志,2019,28(6):676-681.
[2] 赵楠,薛晖,苏晗,等.胰岛素样生长因子结合蛋白-7在急性心力衰竭所致呼吸困难诊断中的应用[J].中国医科大学学报,2023,52(2):110-114.
[3] 韩雅玲.遵循新指南:优化心力衰竭患者的诊断、治疗和管理[J].中华心血管病杂志,2018,46(10):753-755.
[4] LUO J C, ZHANG Y J, HUANG D L, et al. Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure[J].ESC Heart Fail,2022, 9(4):2635-2644.
[5] 廖荣华,谢恒元,江春玲,等.心力衰竭治疗药物的临床应用进展[J].中国新药与临床杂志,2022,41(4):193-200.
[6] PENG Y, WEI H. Role of recombinant human brain natriuretic peptide combined with sodium nitroprusside in improving quality of life and cardiac function in patients with acute heart failure[J].Exp Ther Med,2020, 20(1):261-268.
[7] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南(2018)[J].中华心血管病杂志,2018,46(10):760-789.
[8] 中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等.急性心力衰竭中国急诊管理指南(2022)[J].中国急救医学,2022,42(8):648-670.
[9] LYU J, SUN X, CHEN M, et al. Opioids for treating refractory dyspnea in patients with heart failure: A protocol for systematic review and meta-analysis[J].Medicine (Baltimore),2022,101(47):e31699.
[10] 王华,杨杰孚.中国心力衰竭防控的回顾与展望[J].中华心血管病杂志,2019,47(9):714-717.
[11] 刘培君,康秀峰,雷晓亭,等.重组人脑利钠肽对慢性心衰大鼠免疫和FAK、Bax、Bcl-2、p53的影响及相关性分析[J].中国免疫学杂志,2022,38(17):2079-2081.
[12] 辛秋平,曲忠慧,高志旭.无创正压通气辅助重组人脑利钠肽对老年心力衰竭患者心功能及血气状态的影响[J].中国老年学杂志,2023,43(6):1285-1290.
[13] ZHANG J H, LUO Q, CHEN R C. Patient-ventilator interaction with noninvasive proportional assist ventilation in subjects with COPD[J].Respir Care,2020,65(1):45-52.
[14] SIMONATO M, PADALINO M, VEDOVELLI L,et al. Effect of preoperative pulmonary hemodynamic and cardiopulmonary bypass on lung function in children with congenital heart disease[J].Eur J Pediatr,2023,182(6):2549-2557.